SECOND LINE IMMUNE SUPPRESSIVE DRUGS IN FREQUENTLY RELAPSING CHILDHOOD NEPHROTIC SYNDROME: A 3-ARM RANDOMIZED TRIAL COMPARING CYCLOPHOSPHAMIDE, TACROLIMUS & MYCOPHENOLATE MOFETIL [SELECT]

Registry ID

SELECT2023

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

GOVERNORS OF THE UNIVERSITY OF CALGARY

Last update

2023-09-06

Conditions

• NEPHROTIC SYNDROME

View on source registry